Cleared Traditional

K884972 - TRANSCOUTANEOUS ELECTRO-NEURO STIMULATOR

K884972 is an FDA 510(k) clearance for TRANSCOUTANEOUS ELECTRO-NEURO STIMULATOR, manufactured by Futuremed Div. of Future Impex Corp.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 239-day FDA review.

K884972 · Futuremed Div. of Future Impex Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1989
Decision
239d
Days
Class 2
Risk

K884972 is an FDA 510(k) clearance for the TRANSCOUTANEOUS ELECTRO-NEURO STIMULATOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Futuremed Div. of Future Impex Corp. (Deerpark, US). The FDA issued a Cleared decision on July 27, 1989 after a review of 239 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Futuremed Div. of Future Impex Corp. devices

FDA 510(k) Submission Details - K884972

510(k) Number K884972 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 1988
Decision Date July 27, 1989
Days to Decision 239 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 148d · This submission: 239d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 174
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K884972.
TTS2700 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR
K895211 · Henley Intl. · Oct 1989
TTS2600
K895334 · Henley Intl. · Oct 1989
TENZCARE STIMULATOR 6890
K891992 · 3M Company · Oct 1989
MODIFIED MRL NEUROPROBE SYSTEM V
K884869 · Medical Research Laboratories, Inc. · Jun 1989
EMPI, MODEL 489, TENS
K890604 · Empi · Jun 1989
MEDIMOD(TM), MODEL 8900
K890705 · Medical Devices, Inc. · Mar 1989